News
Investor's Business Daily on MSN37m
Biohaven Surges After FDA Cancels Key Meeting. But Is It Good News?
Biohaven stock surged early Friday after the FDA canceled an upcoming meeting to discuss the benefits and risks of its drug, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback